Updated

Guardant Health shares were reported nearing a technical buy point as the company's sales outlook brightened, according to Yahoo Finance. The improving forecast has drawn renewed investor attention to the diagnostics company. The development reflects broader investor interest in growth-oriented healthcare diagnostics firms amid a mixed backdrop for the health care sector.